银诺医药-B(02591)认购1.05亿元宁波银行结构性存款产品

Core Viewpoint - Silver诺医药-B (02591) announced the subscription of a structured deposit product from Ningbo Bank for a total consideration of RMB 105 million, which is equivalent to its total principal amount [1] Group 1 - The company, along with its wholly-owned subsidiary Silver诺技术, will invest in the structured deposit product [1] - The transaction is set to take place on November 3, 2025 [1]